Direct-to-Consumer Platforms for New Antiobesity Medications - Concerns and Potential Opportunities

N Engl J Med. 2024 Feb 22;390(8):677-680. doi: 10.1056/NEJMp2312816. Epub 2024 Feb 17.
No abstract available

MeSH terms

  • Anti-Obesity Agents* / adverse effects
  • Anti-Obesity Agents* / therapeutic use
  • Direct-to-Consumer Advertising*
  • Humans
  • Obesity* / drug therapy

Substances

  • Anti-Obesity Agents